Verition Fund Management’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1M Buy
915,000
+59,430
+7% +$2.39M 0.18% 108
2026
Q1
$38.1M Buy
855,570
+105,570
+14% +$4.66M 0.25% 61
2025
Q4
$31.5M Buy
+750,000
New +$31.7M 0.12% 112

Other funds holding MDLN

Verition Fund Management's MDLN Position: Q2 2026 in Review

Verition Fund Management increased its Medline Inc (MDLN) stake by 6.9% in Q2 2026, buying an estimated $2.39M and bringing the position to 915,000 shares worth $36.1M. The position accounts for 0.18% of the portfolio, ranked #108.

Verition Fund Management first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $38.1M in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Verition Fund Management held 915,000 shares of Medline Inc worth $36.1M as of Q2 2026.
  • Verition Fund Management bought 59,430 Medline Inc shares in Q2 2026, an estimated $2.39M.
  • Medline Inc made up 0.18% of Verition Fund Management's portfolio in Q2 2026, its #108 holding.
  • Verition Fund Management first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Verition Fund Management's Medline Inc position peaked at $38.1M in Q1 2026.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.